Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.32 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.32 |
| ▸ | CCNC | P24863 | 1/20 | 0.32 |
| ▸ | CDK8 | P49336 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24859973 | 0.98 | HPGD (0.30) | MAPT | |
| SCHEMBL15852047 | 0.90 | ALDH1A1 (0.32) | — | |
| SCHEMBL15852054 | 0.89 | AHR (0.32) | — | |
| SCHEMBL21907293 | 0.88 | HPGD (0.33) | MAPTHSD17B1HSD17B2CCNCCDK8 | |
| SCHEMBL15852042 | 0.88 | TDP1 (0.33) | — | |
| SCHEMBL21870051 | 0.88 | MAPT (0.30) | MAPT | |
| SCHEMBL15852053 | 0.87 | CCNC (0.32) | CCNCCDK8 | |
| SCHEMBL23131484 | 0.86 | PTPRF (0.33) | MAPT | |
| SCHEMBL19308057 | 0.86 | CCNC (0.34) | MAPTCCNCCDK8L3MBTL1 | |
| SCHEMBL15852271 | 0.86 | HSD17B1 (0.35) | MAPTHSD17B1HSD17B2CCNCCDK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230011996-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2023-01-12 | — | — | US | disclosed |
| US-20210384430-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-12-09 | — | — | US | disclosed |
| US-10811612-B2 | Organic electroluminescence device and electronic apparatus provided with the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-10-20 | — | — | US | disclosed |
| US-10804474-B2 | Organic electroluminescence device and electronic apparatus provided with the same | IDEMITSU KOSAN CO., LTD. (JP) | 2020-10-13 | — | — | US | disclosed |
| US-20200111962-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2020-04-09 | — | — | US | disclosed |
| US-20200111974-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2020-04-09 | — | — | US | disclosed |
| US-20200111965-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2020-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200111965-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | RER1, RPS19, ESR1 | MAPT 4304/4885HSD17B1 2247/4885HSD17B2 2165/4885 |
| US-20230011996-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | RER1, RPS19, ESR1 | MAPT 4227/4885HSD17B1 2155/4885HSD17B2 2096/4885 |
| US-10811612-B2 | Organic electroluminescence device and electronic apparatus provided with the same | RER1, RPS19, ESR1 | MAPT 4304/4885HSD17B1 2247/4885HSD17B2 2165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.